Samyang Biopharm Corporation Stock: price and insider trades · South Korea
삼양바이오팜
1 insider bought shares over the last 90 days, the latest by 김태헌, filed 05 Nov 2026.
Samyang Biopharm Corporation: what insiders have been doing
This page follows insider dealings at Samyang Biopharm Corporation as filed with DART (FSS), a company from the Health Care sector. 7 insiders have disclosed 10 filings since 5 November 2025.
No insider sold shares on the market over the period. Instead, the filings list 7 purchases, made by 6 insiders. No amount is published for 7 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The buyers include 1 major shareholder.
Across the 2,656 companies tracked on its exchange, the median is 7 filings; at 10 filings, this issuer sits above that mark. Our records for Samyang Biopharm Corporation go back to 2025, with 7 purchases and no sales on the open market in total.
The last insider purchase was made public on 5 November 2026, 3 days ago. Filings reach the DART (FSS) feed a median of 7 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleFinancial data
· cache
- 130 sharesShareKRXDART:20261105000557Canonical exit: 3 Feb 2027 (T+90)
- Other0DART
- 0KRXDART:20260319001160
- 0KRXDART:20260304001303
- ●Executives0DART
- Other0DART
- 431,517 sharesShareKRXDART:20251126000701Canonical exit: 24 Feb 2026 (T+90)
- 238,235 sharesShareKRXDART:20251126000705Canonical exit: 24 Feb 2026 (T+90)
- 257,491 sharesShareKRXDART:20251126000699Canonical exit: 24 Feb 2026 (T+90)
- 314,810 sharesShareKRXDART:20251126000713Canonical exit: 24 Feb 2026 (T+90)
- 387,553 sharesShareKRXDART:20251126000709Canonical exit: 24 Feb 2026 (T+90)
- 3,449,570 sharesKRXDART:20251126000693Canonical exit: 22 Feb 2026 (T+90)
12 of 12 declarations
About Samyang Biopharm Corporation
Samyang Biopharm is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and manufacturing of pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
